34734811000001103: Glecaprevir 100mg / Pibrentasvir 40mg tablets (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Virtual medicinal product\Glecaprevir 100mg / Pibrentasvir 40mg tablets
\UK product\Virtual therapeutic moiety\Glecaprevir + Pibrentasvir\Glecaprevir 100mg / Pibrentasvir 40mg tablets

\Medicinal product\Medicinal product categorized by disposition\Product containing Hepatitis C virus protein NS5A inhibitor (product)\Product containing pibrentasvir (medicinal product)\Product containing glecaprevir and pibrentasvir\Glecaprevir + Pibrentasvir\Glecaprevir 100mg / Pibrentasvir 40mg tablets
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing protease inhibitor\Product containing Hepatitis C virus NS3/4A protease inhibitor (product)\Product containing glecaprevir (medicinal product)\Product containing glecaprevir and pibrentasvir\Glecaprevir + Pibrentasvir\Glecaprevir 100mg / Pibrentasvir 40mg tablets
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing pyrrolidine\Product containing pibrentasvir (medicinal product)\Product containing glecaprevir and pibrentasvir\Glecaprevir + Pibrentasvir\Glecaprevir 100mg / Pibrentasvir 40mg tablets
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing sulfonamide\Product containing glecaprevir (medicinal product)\Product containing glecaprevir and pibrentasvir\Glecaprevir + Pibrentasvir\Glecaprevir 100mg / Pibrentasvir 40mg tablets
\Medicinal product\Medicinal product categorized by structure\Product containing sulfur and/or sulfur compound (product)\Product containing sulfonamide\Product containing glecaprevir (medicinal product)\Product containing glecaprevir and pibrentasvir\Glecaprevir + Pibrentasvir\Glecaprevir 100mg / Pibrentasvir 40mg tablets
\Medicinal product\Medicinal product categorized by structure\Product containing benzimidazole\Product containing pibrentasvir (medicinal product)\Product containing glecaprevir and pibrentasvir\Glecaprevir + Pibrentasvir\Glecaprevir 100mg / Pibrentasvir 40mg tablets
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiviral agent (product)\Product containing pibrentasvir (medicinal product)\Product containing glecaprevir and pibrentasvir\Glecaprevir + Pibrentasvir\Glecaprevir 100mg / Pibrentasvir 40mg tablets
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiviral agent (product)\Product containing glecaprevir (medicinal product)\Product containing glecaprevir and pibrentasvir\Glecaprevir + Pibrentasvir\Glecaprevir 100mg / Pibrentasvir 40mg tablets

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 13-Sep 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

104986401000001115 Glecaprevir 100mg / Pibrentasvir 40mg tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

104986501000001116 Glecaprevir 100mg / Pibrentasvir 40mg tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Glecaprevir 100mg / Pibrentasvir 40mg tablets	Is a	Glecaprevir + Pibrentasvir	true	Inferred relationship	Existential restriction modifier
Glecaprevir 100mg / Pibrentasvir 40mg tablets	Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration	Oral route	true	Inferred relationship	Existential restriction modifier
Glecaprevir 100mg / Pibrentasvir 40mg tablets	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Glecaprevir 100mg / Pibrentasvir 40mg tablets	Has NHS dm+d (dictionary of medicines and devices) dose form indicator	Discrete dose form indicator	true	Inferred relationship	Existential restriction modifier
Glecaprevir 100mg / Pibrentasvir 40mg tablets	Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route	tablet.oral ontology form and route	true	Inferred relationship	Existential restriction modifier
Glecaprevir 100mg / Pibrentasvir 40mg tablets	Plays role	Antiviral therapeutic role	true	Inferred relationship	Existential restriction modifier
Glecaprevir 100mg / Pibrentasvir 40mg tablets	Is a	Glecaprevir + Pibrentasvir	false	Inferred relationship	Existential restriction modifier
Glecaprevir 100mg / Pibrentasvir 40mg tablets	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Glecaprevir 100mg / Pibrentasvir 40mg tablets	Has specific active ingredient	Pibrentasvir	false	Inferred relationship	Existential restriction modifier
Glecaprevir 100mg / Pibrentasvir 40mg tablets	Has specific active ingredient	Glecaprevir	false	Inferred relationship	Existential restriction modifier
Glecaprevir 100mg / Pibrentasvir 40mg tablets	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Glecaprevir 100mg / Pibrentasvir 40mg tablets	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Glecaprevir 100mg / Pibrentasvir 40mg tablets	Is a	Virtual medicinal product	true	Inferred relationship	Existential restriction modifier
Glecaprevir 100mg / Pibrentasvir 40mg tablets	Has active ingredient	Substance with antiviral mechanism of action	false	Inferred relationship	Existential restriction modifier
Glecaprevir 100mg / Pibrentasvir 40mg tablets	Has manufactured dose form	Tablet	false	Inferred relationship	Existential restriction modifier
Glecaprevir 100mg / Pibrentasvir 40mg tablets	Has specific active ingredient	Pibrentasvir	true	Inferred relationship	Existential restriction modifier
Glecaprevir 100mg / Pibrentasvir 40mg tablets	Has specific active ingredient	Glecaprevir	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Maviret 100mg/40mg tablets (AbbVie Ltd)	Is a	True	Glecaprevir 100mg / Pibrentasvir 40mg tablets	Inferred relationship	Existential restriction modifier
Glecaprevir 100mg / Pibrentasvir 40mg tablets 84 tablet	Has VMP	True	Glecaprevir 100mg / Pibrentasvir 40mg tablets	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
104986401000001115	Glecaprevir 100mg / Pibrentasvir 40mg tablets (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
104986501000001116	Glecaprevir 100mg / Pibrentasvir 40mg tablets	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module